Associate Professor, Surgical Oncology Research, Department of Surgery, Emory University School of Medicine

MD, Department of Medicine, West China University of Medical Sciences, Chengdu, Sichuan Province, China, 1978-1983

Master of Medicine, Microbiology and Immunology, Institute of Epidemiology and Microbiology, Chinese Academy of Preventive Medicine, Beijing, China, 1983-1986

PhD, Program in Molecular and Cell Biology & Biochemistry, Brown University, Providence, RI, 1988-1993

Research Associate, Department of Immunology, Beijing Institute for Cancer Research, Beijing, China, 1986-1988

Postdoctoral Associate, Brown University-Rhode Island Hospital, 1993

Research Associate and Director of Animal Study, University of Southern California School of Medicine, Los Angeles, CA, 1993-1995

Research Associate, Emory, 1995-1996

Research Fellow, Group Leader For Anti-Angiogenesis Pre-Clinical Study, Aventis Gencell, Hayward, CA, 1998-1999

Apoptosis

Nanomedicine

American Association for Cancer Research

American Academy of Nanomedicine, Fellow

Scientific Peer Review Panel Member, Breast Cancer Research Program, Department of Defense

Pathogenesis Committee, California Breast Cancer Research Program

Society of Molecular Imaging

Targeting the inhibitor of the apoptosis family of proteins, such as survivin and XIAP, for cancer therapy.

Studying signal pathways and molecular mechanisms that confer aggressive behavior of CD44+ breast cancer cells (putative breast cancer stem cells).

Investigating molecular pathways promoting the progression of breast cancer from ductal carcinoma in situ to invasive breast cancer.

The development of multifunctional nanoparticles for cancer detection using targeted tumor optical and MR imaging, drug delivery, and monitoring therapeutic responses.